Esophageal Cancer: Radiation Therapy Planning
Fig. 4.1 The esophagus is divided into four regions by the AJCC. The cervical esophagus extends from the upper esophageal sphincter to the thoracic inlet. The upper thoracic esophagus extends…
Pancreatic Cancer: Radiation Therapy Planning
Structure Unresectable/neoadjuvant recommendationsa Adjuvant/resected recommendationsb Kidney (right and left) Not more than 30 % of the total volume can receive ≥18 Gy. If only one kidney is functional, not more…
Biliary Cancer: Radiation Therapy Planning
Fig. 12.1 Representative contours for postoperative external beam radiotherapy of a pT2N1M0 stage IIIB adenocarcinoma of the gallbladder. Representative axial (a) and coronal (b) sections of the tumor bed ITV…
Stereotactic Body Radiation Therapy for Liver Metastases: Radiation Therapy Planning
Fig. 18.1 Patient with oligometastatic pancreatic cancer with an enlarging right hepatic lobe segment 6 lesion measuring 1.8 cm, treated with stereotactic body radiation, 54 Gy in three fractions. Axial…
Stereotactic Body Radiation Therapy for Liver Metastases: Background and Clinical Evidence
Study Inclusion Number of patients Type of metastasis Total dose per fraction Toxicity Median follow-up (months) Local control rate Survival Herfarth et al. (2001) [38] 1–3 lesions 37 Not reported…
Anal Cancer: Background and Clinical Evidence
T1 ≤ 2 cm N1 Perirectal node(s) M0 No distant metastasis T2 2–5 cm N2 Unilateral internal iliac and/or inguinal node(s) M1 Distant metastasis T3 > 5 cm N3 Perirectal…
Rectal and Colon Cancer: Background and Clinical Evidence
(1) Harvard Radiation Oncology Program, Boston, MA, USA (2) Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, MA, USA (3) Massachusetts General Hospital, Boston, MA, USA Sophia C. Kamran…
Biliary Cancer: Background and Clinical Evidence
Isolated locoregional failure rate (%) Initial distant failure rate (%) Extrahepatic/hilar cholangiocarcinoma Surgery alone 4–34 24–40 +adjuvant chemoradiotherapy (SWOG 0809) 8 29 Gallbladder cancer Surgery alonea 3–33 15–51 +adjuvant…
Primary Liver Cancer: Background and Clinical Evidence
1 point 2 points 3 points Total bilirubin (mg/dl)a <3.4 3.4–5.0 >5.0 INR <1.7 1.7–2.3 >2.3 Albumin (g/dl) >3.5 2.8–3.5 <2.8 Ascites None Mild Moderate–severe Hepatic encephalopathy None Medically…
Gastric Cancer: Background and Clinical Evidence
© Springer International Publishing AG 2017Theodore Hong and Prajnan Das (eds.)Radiation Therapy for Gastrointestinal Cancers10.1007/978-3-319-43115-4_5 5. Gastric Cancer: Background and Clinical Evidence Christopher L. Hallemeier1 and Michael G. Haddock1 (1) Mayo Clinic, Rochester, MN 55905, USA Michael G. Haddock Email:…
